麦格理发表研究报告指，创科(00669.HK) 旗下品牌Milwaukee收入贡献持续提升，预料今年占比达到70%，有助推动全年EBIT利润率料扩大至9.2%，同时更高的资本开支将带动生产力和效率进一步提升，维持“跑赢大市”评级，预计Milwaukee 2025年收入将增长11%，集团整体收入料增长7%。
麦格理指，创科拥有强劲的自由现金流生成能力，预计今年将达至净现金状态，2026年EBIT利润率则可进一步扩张至10%，相信潜在新关税政策的影响仍可控，基于更高的EBIT利润率预测，将2025至2026年净利润预测上调1.6%及1.2%，目标价格上调12%至134元，相当于预测明年市盈率19.6倍。(gc/da)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-05 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.